Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8V5I

Crystal structure of MAP4K4 in complex with an inhibitor

This is a non-PDB format compatible entry.
Summary for 8V5I
Entry DOI10.2210/pdb8v5i/pdb
DescriptorMitogen-activated protein kinase kinase kinase kinase 4, (3M)-N~6~-(1,4-dimethyl-1H-pyrazol-3-yl)-3-(1-methyl-1H-imidazol-5-yl)-2,7-naphthyridine-1,6-diamine (2 entities in total)
Functional Keywordskinase, inhibitor, mitogen-activated protein kinase kinase kinase kinase 4, transferase, transferase-inhibitor complex, transferase/inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight73878.90
Authors
Greasley, S.E.,Diehl, W. (deposition date: 2023-11-30, release date: 2025-01-22)
Primary citationGallego, R.A.,Scales, S.,Toledo, C.,Auth, M.,Bernier, L.,Berry, M.,Brun, S.,Chung, L.,Davis, C.,Diehl, W.,Dress, K.,Eisele, K.,Elleraas, J.,Ewanicki, J.,Fobian, Y.,Greasley, S.,Greenwald, E.C.,Johnson, T.W.,Khamphavong, P.,Lafontaine, J.,Li, J.,Linton, A.,Maestre, M.,Miller, N.,Murtaza, A.,Patman, R.L.,Quinlan, C.L.,Ramms, D.J.,Richardson, P.,Sach, N.,Salomon-Ferrer, R.,Silva, F.,Timofeevski, S.,Tran, P.,Tran-Dube, M.,Wang, F.,Wang, W.,Wythes, M.,Yang, S.,Zou, A.,VanArsdale, T.,McAlpine, I.
Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL).
J.Med.Chem., 67:19234-19246, 2024
Cited by
PubMed Abstract: By virtue of its role in cellular proliferation, microtubule-associated serine/threonine kinase-like (MASTL) represents a novel target and a first-in-class (FIC) opportunity to provide a new impactful therapeutic agent to oncology patients. Herein, we describe a hit-to-lead optimization effort that resulted in the delivery of two highly selective MASTL inhibitors. Key strategies leveraged to enable this work included structure-based drug design (SBDD), analysis of lipophilic efficiency (LipE) and novel synthesis. The resulting advanced lead compounds enabled a tumor growth inhibition study which was pivotal in assessing the potential value of MASTL as an oncology therapeutic target.
PubMed: 39499084
DOI: 10.1021/acs.jmedchem.4c01659
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.18 Å)
Structure validation

234785

건을2025-04-16부터공개중

PDB statisticsPDBj update infoContact PDBjnumon